Form D · Biotechnology

RNAV8 BIO, INC.

Laguna Niguel, CA · CIK 0001960745

Offering snapshot reported Mar 17, 2025 · SEC filing

Reported sold
$2.01M
Offering amount: $3M
Investors reported
42
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 9, 2022
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$1.01M$2.01MJan 4, 2023: $599,500.00Jan 4, 2023Jan 4, 2023: $599,500.00Jun 26, 2023: $999,500.00Jun 26, 2023Mar 17, 2025: $2,013,880.00Mar 17, 2025

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$999,500 → $2,013,880
  • Reported investors11 → 42

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 17, 2025Amendment$2,013,880$1,014,380vs Jun 26, 202342SEC filing
Jun 26, 2023Amendment$999,500$400,000vs Jan 4, 202311SEC filing
Jan 4, 2023Initial$599,500No comparison11SEC filing
Jan 4, 2023Amendment$599,500$0vs Jan 4, 202311SEC filing

Offering details

Securities
Option to acquire
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-469573

Source: Form D, filed Mar 17, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Devan Shah Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
29851 Weatherwood
Laguna Niguel, CA, 92677